{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:45:12Z","timestamp":1776768312455,"version":"3.51.2"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and objective<\/jats:title><jats:p>Phenobarbitone is used as a first-line drug for neonatal seizures. However, its poor short- and long-term safety profile is concerning. We aim to systematically synthesize the data on the efficacy and safety of phenobarbitone as a first-line agent and compare it against other anti-epileptic drugs (AEDs) in neonates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using keywords related to the study population (neonatal seizure) and intervention (phenobarbitone), we searched CENTRAL, Embase, PubMed and Web of Science until 15 December 2020. Randomized controlled trials (RCTs) comparing phenobarbitone with any other AED as first-line therapy for seizure control in the neonates were considered eligible. The random-effect meta-analysis was done using RevMan 5.3 software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We screened through 443 records and identified nine eligible studies (719 participants). Five RCTs comparing phenobarbitone with levetiracetam did not find any difference in seizure control with the first dose [risk ratio (RR) 1.43, 95% CI 0.79\u20132.57] or adverse effects (RR 4.66; 95% CI 0.33\u201365.83). Two trials comparing phenobarbitone and phenytoin also did not find any difference in seizure control with the first dose (RR 2.09; 95% CI 0.31\u201314.03) and other outcomes. Only one RCT compared phenobarbitone and lorazepam and found lorazepam to be more efficacious in seizure control with the first dose (RR 0.71; 95% CI 0.53\u20130.94). Three trials compared neurodevelopmental outcomes, in which levetiracetam was better in two, whereas one did not find any difference.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Phenobarbitone is at least as efficacious and safe as other drugs like phenytoin and levetiracetam. The data over the long-term neurodevelopmental outcome are lacking. The existing evidence is insufficient to recommend other drugs over phenobarbitone.<\/jats:p><\/jats:sec>","DOI":"10.1093\/tropej\/fmab008","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T23:32:05Z","timestamp":1612308725000},"source":"Crossref","is-referenced-by-count":15,"title":["Efficacy and Safety of Phenobarbitone as First-Line Treatment for Neonatal Seizure: A Systematic Review and Meta-Analysis"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0464-9689","authenticated-orcid":false,"given":"Jogender","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitendra","family":"Meena","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-3469","authenticated-orcid":false,"given":"Jaivinder","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokesh","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"2021021801383210100_fmab008-B1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.siny.2013.05.008","article-title":"Epidemiology and aetiology of neonatal seizures","volume":"18","author":"Vasudevan","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"key":"2021021801383210100_fmab008-B2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.siny.2013.01.002","article-title":"Outcome following neonatal seizures","volume":"18","author":"Uria-Avellanal","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"key":"2021021801383210100_fmab008-B3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.clp.2009.07.012","article-title":"The long-term effects of neonatal seizures","volume":"36","author":"Holmes","year":"2009","journal-title":"Clin Perinatol"},{"key":"2021021801383210100_fmab008-B4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/WNL.55.4.506","article-title":"Electrographic seizures in neonates correlate with poor neurodevelopmental outcome","volume":"55","author":"McBride","year":"2000","journal-title":"Neurology"},{"key":"2021021801383210100_fmab008-B5","doi-asserted-by":"crossref","first-page":"e20193182","DOI":"10.1542\/peds.2019-3182","article-title":"Levetiracetam Versus Phenobarbital for Neonatal Seizures: a Randomized Controlled Trial","volume":"145","author":"Sharpe","year":"2020","journal-title":"Pediatrics"},{"key":"2021021801383210100_fmab008-B6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clp.2013.10.004","article-title":"Neonatal seizures: advances in mechanisms and management","volume":"41","author":"Glass","year":"2014","journal-title":"Clin Perinatol"},{"key":"2021021801383210100_fmab008-B7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jpeds.2009.03.040","article-title":"Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury","volume":"155","author":"Glass","year":"2009","journal-title":"J Pediatr"},{"key":"2021021801383210100_fmab008-B8","doi-asserted-by":"crossref","first-page":"e358-366","DOI":"10.1542\/peds.2009-0136","article-title":"Effect of treatment of subclinical neonatal seizures detected with aEEG: randomized, controlled trial","volume":"125","author":"van Rooij","year":"2010","journal-title":"Pediatrics"},{"key":"2021021801383210100_fmab008-B9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0883073812470734","article-title":"Pharmacological treatment of neonatal seizures: a systematic review","volume":"28","author":"Slaughter","year":"2013","journal-title":"J Child Neurol"},{"key":"2021021801383210100_fmab008-B10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N Engl J Med"},{"key":"2021021801383210100_fmab008-B11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.siny.2017.07.008","article-title":"The use of phenobarbital and other anti-seizure drugs in newborns","volume":"22","author":"El-Dib","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"key":"2021021801383210100_fmab008-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3683548","article-title":"Short-term neurodevelopmental outcome in term neonates treated with phenobarbital versus levetiracetam: a single-center experience","volume":"2019","author":"Falsaperla","year":"2019","journal-title":"Behav Neurol"},{"key":"2021021801383210100_fmab008-B13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/jp.2013.116","article-title":"Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures","volume":"33","author":"Ma\u00eetre","year":"2013","journal-title":"J Perinatol"},{"key":"2021021801383210100_fmab008-B14","doi-asserted-by":"crossref","first-page":"e207-211","DOI":"10.1111\/j.1528-1167.2011.03297.x","article-title":"Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain","volume":"52","author":"Forcelli","year":"2011","journal-title":"Epilepsia"},{"key":"2021021801383210100_fmab008-B15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/epi.13365","article-title":"Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain","volume":"57","author":"Kaushal","year":"2016","journal-title":"Epilepsia"},{"key":"2021021801383210100_fmab008-B16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","article-title":"Use of intravenous levetiracetam for management of acute seizures in neonates","volume":"44","author":"Khan","year":"2011","journal-title":"Pediatr Neurol"},{"key":"2021021801383210100_fmab008-B17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0883073810384263","article-title":"Levetiracetam for treatment of neonatal seizures","volume":"26","author":"Abend","year":"2011","journal-title":"J Child Neurol"},{"key":"2021021801383210100_fmab008-B18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13312-019-1586-3","article-title":"Levetiracetam versus phenobarbitone in neonatal seizures\u2014a randomized controlled trial","volume":"56","author":"Gowda","year":"2019","journal-title":"Indian Pediatr"},{"key":"2021021801383210100_fmab008-B19","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2021021801383210100_fmab008-B20","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2021021801383210100_fmab008-B21","author":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]","year":"2020"},{"key":"2021021801383210100_fmab008-B22","author":"Sch\u00fcnemann","year":"2013"},{"key":"2021021801383210100_fmab008-B23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/2249-4847.161696","article-title":"Comparative efficacy of phenobarbital, phenytoin and lorazepam for the treatment of neonatal seizures: a randomized Trial","volume":"4","author":"Solanki","year":"2015","journal-title":"J Clin Neonatol"},{"key":"2021021801383210100_fmab008-B24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13312-013-0218-6","article-title":"Phenobarbitone versus phenytoin for treatment of neonatal seizures: an open-label randomized controlled trial","volume":"50","author":"Pathak","year":"2013","journal-title":"Indian Pediatr"},{"key":"2021021801383210100_fmab008-B25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3329\/bjch.v42i2.37761","article-title":"Randomized controlled trial between levetiracetam and phenobarbital in the treatment of neonatal seizure due to perinatal asphyxia","volume":"42","author":"Md Pervez","year":"2018","journal-title":"Bangladesh J Child Health"},{"key":"2021021801383210100_fmab008-B26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.32677\/IJCH.2019.v06.i11.008","article-title":"Neonatal seizures\u2014levetiracetam versus phenobarbital","volume":"06","author":"Prakash","year":"2019","journal-title":"Indian J Child Health"},{"key":"2021021801383210100_fmab008-B27","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.18203\/2320-6012.ijrms20161763","article-title":"A randomized controlled trial on comparison of phenobarbitone and levetiracetam for the treatment of neonatal seizures: pilot study","author":"Perveen","year":"2016","journal-title":"Int J Res Med Sci"},{"key":"2021021801383210100_fmab008-B28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/00207454.2019.1687469","article-title":"Efficacy and safety of levetiracetam in the off-label treatment of neonatal seizures","volume":"130","author":"Liu","year":"2020","journal-title":"Int J Neurosci"},{"key":"2021021801383210100_fmab008-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","article-title":"Levetiracetam: safety and efficacy in neonatal seizures","volume":"15","author":"Ramantani","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"2021021801383210100_fmab008-B30","doi-asserted-by":"crossref","first-page":"012","DOI":"10.1055\/s-0037-1608653","article-title":"A systematic review of the efficacy of levetiracetam in neonatal seizures","volume":"49","author":"McHugh","year":"2018","journal-title":"Neuropediatrics"},{"key":"2021021801383210100_fmab008-B31","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00381-019-04286-x","article-title":"Neurodevelopmental outcomes at 9\u201314 months gestational age after treatment of neonatal seizures due to brain injury","volume":"35","author":"Ghosh","year":"2019","journal-title":"Childs Nerv Syst"},{"key":"2021021801383210100_fmab008-B32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2471\/BLT.12.113183","article-title":"Phenobarbital: missing in action","volume":"90","author":"Ilangaratne","year":"2012","journal-title":"Bull World Health Organ"},{"key":"2021021801383210100_fmab008-B33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s13104-018-3617-x","article-title":"Availability and sufficiency of phenobarbital, an essential medication, in Bhutan: a survey of global and neuropsychiatric relevance","volume":"11","author":"Bhalla","year":"2018","journal-title":"BMC Res Notes"},{"key":"2021021801383210100_fmab008-B34","author":"Government PHARMAC New Zealand"},{"key":"2021021801383210100_fmab008-B35","author":"Junaidi","year":"2020"}],"container-title":["Journal of Tropical Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/tropej\/article-pdf\/67\/1\/fmab008\/36302596\/fmab008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/tropej\/article-pdf\/67\/1\/fmab008\/36302596\/fmab008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T02:58:24Z","timestamp":1697770704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/tropej\/article\/doi\/10.1093\/tropej\/fmab008\/6141527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,29]]}},"URL":"https:\/\/doi.org\/10.1093\/tropej\/fmab008","relation":{},"ISSN":["0142-6338","1465-3664"],"issn-type":[{"value":"0142-6338","type":"print"},{"value":"1465-3664","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2021,1,29]]},"article-number":"fmab008"}}